Skip to Navigation
Skip to Main Content
Skip to Related Content
to view your mail
Yahoo Finance Plus
U.S. markets open in 4 hours 25 minutes
Russell 2000 Futures
Mustang Bio, Inc. (MBIO)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 4:00PM EDT
702 reactions on $MBIO conversation
Sign in to post a message.
This stock shows only bullish information…. When this stock goes to a $1 billion market cap, buyers are going to wish they had this in there portfolio. The CEO bought 250k worth of stock at 2.91…. So he knows that this company will be the real deal in the future. With the market hitting all time highs and the T2108 only showing 40 companies in the S&P are trading above the 40 day moving average just proves that companies like this with massive cash piles and creating a pipeline of new drugs is just as risky right now as putting you money in blue collar stocks
It appears downtrend has been broken, we need more volume in the weeks ahead. bullish
I am relatively new to investing in biotech sector, it appears stocks stay flat until approval of their products for distribution by FDA. Huge spike.
Any opportunity here for a $TRIL like buyout?
Who’s is selling $Mbio here? I don’t get it. I know it’s a slow burner and will take a while for news to flow, however all news has been positive, balance sheet looks great…. Why sell at the bottom of this range! People should be buying.
Great Great News today !
Yahoo Finance Insights
Mustang Bio is up 6.39% to 2.83
A six-month low. Really?
Held this long enough hoping for a big gain. I don’t expect one is coming . I’m out. Good luck to the longs.
Volume up substantially
Up a penny one day down a penny the next...this stock is going nowhere ...have been in it for 2 years
Seems like good news today.
Yet stock opening down.
Was the good news already priced in? :-)
Keep a hot look for earnings call 08/10.
Have held this stock for over a year…doesn’t seem to have any upside
The catalyst for stock appreciation... Title: Third Generation CD20 Targeted CAR T-Cell Therapy (MB-106) for Treatment of Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Session: 704. Immunotherapies: Poster I
Date and Time: Saturday, December 5, 2020, 10:00 a.m. - 6:30 p.m. ET
Presenter: Mazyar Shadman, M.D., M.P.H., Associate Professor, Clinical Research Division, Fred Hutch, Seattle, WA
For more information, please visit the 62nd ASH Annual Meeting and Exposition website at
Director bought 100,000 shares worth $266,000 on December 14,2020.
Some good news is coming soon. buy before it flies
Genetically engineered immune cells that targets glioblastomas! Very exciting and congrats to the company and the family of the first dosed patient (today). This is what science is all about..
They announced nothing at the Investor meeting. It was a few minutes long and only to have shareholders vote on retaining existing officers. I think the sell off is just short term traders banking on positive news being announced today. Investors should be patient and accumulate at these prices as there are a lot of trial data to be released in the coming weeks/months.
had a mention on Clayman Countdown today. one of the guests, not sure what his name was, said MBIO would be in mid teens by next year. I dont own MBIO but am looking into this stock to see if it has potential.
All the States That Don’t Tax Social Security
Fed Chair Powell orders review after Fed members report big investments
Yahoo Finance Video
Should I rent or buy a home right now? Well, that depends on where you want to live.
Advertise with us
© 2021 Verizon Media. All rights reserved.
About Our Ads
Discover new investment ideas by accessing unbiased, in-depth investment research